Sodium Nitroprusside Injection, Solution, Concentrate
Product Images NDC 70069-261

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 70069-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7d0f6512 83e7 4bd7 B10e Ef6dc183be82 01

Chemical structure of Sodium Nitroprusside depicting an iron (Fe) center bonded to five cyanide (CN) groups and one nitrosyl (ON) group, with two sodium ions (Na+) and two water molecules (H2O) indicated.*

FDA Label Image

7d0f6512 83e7 4bd7 B10e Ef6dc183be82 02

An illustration diagram depicting the metabolism of Sodium Nitroprusside, showing the biochemical pathways involving cytochromes, cyanide, metHgb, thiosulfate, thiocyanate, and related renal excretion processes.*

FDA Label Image

7d0f6512 83e7 4bd7 B10e Ef6dc183be82 03

Label for Sodium Nitroprusside Injection showing 50 mg/2 mL (25 mg/mL) concentration in a 2 mL single-dose vial. The label indicates it is for intravenous infusion only and should be protected from light. Manufactured for Somerset Therapeutics, LLC, Hollywood, FL, with storage instructions and a barcode included.*

FDA Label Image

7d0f6512 83e7 4bd7 B10e Ef6dc183be82 04

Label for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) solution concentrate, intravenous use, in a 2 mL single-dose vial. The label specifies dilution requirements, storage instructions, and safety warnings about blood pressure monitoring. It is manufactured for Somerset Therapeutics LLC, Hollywood, FL. Includes barcode and manufacturing details indicating origin in India.*

FDA Label Image

7d0f6512 83e7 4bd7 B10e Ef6dc183be82 05

Text panel for Sodium Nitroprusside Injection infusion solution including spaces to fill in the amount of drug and volume of 5% Dextrose Injection USP. Instructions emphasize protection from light, discarding solution 24 hours after dilution, and not adding other medications to the infusion. Manufacturer information for Somerset Therapeutics, LLC is also included, along with a note that the product is made in India.*

FDA Label Image

7d0f6512 83e7 4bd7 B10e Ef6dc183be82 06

This image includes text regarding a light protective sleeve for Sodium Nitroprusside (Infusion). It states that the infusion solution must be protected from light by covering it with the enclosed light protective sleeve or other opaque material. The text is repeated twice and includes a revision date of 11/2019.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.